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Abstract
Nigeria has the highest burden of NTDs in sub-Saharan Africa. Commitments to reach the
control and elimination of many Neglected Tropical Diseases (NTDs), particularly those ame-
nable to preventive chemotherapy (onchocerciasis, schistosomiasis, soil transmitted hel-
minths, lymphatic filariasis and trachoma) by 2020 are detailed in the London declaration.
Strategies to reach targets build on existing approaches, one of which is the use of community
directed intervention (CDI) methods to deliver the mass administration of medicines (MAM).
However, treatment using this approach has been inconsistent and there are questions about
the acceptability and adaptability of these interventions during periods of programmatic,
social, and political change. This paper explores the current strengths and weaknesses of CDI
approaches in MAM delivery. We consider the acceptability and adaptability of existing MAM
approaches to ensure equity in access to essential treatments. Using qualitative methods, we
explore implementer perspectives of MAM delivery. We purposively selected programme
implementers to ensure good programmatic knowledge and representation from the different
levels of health governance in Nigeria. Data collection took place across two States (Kaduna
and Ogun). Our results indicate that CDI approaches have underpinned many historic suc-
cesses in NTD programme acceptance in Nigeria, specifically in Kaduna and Ogun State.
However, our results also show that in some contexts, factors that underpin the success of
CDI have become disrupted presenting new challenges for programme implementers. Cap-
turing the tacit knowledge of health implementers at varying levels of the health system, we
present the current and changing context of MAM delivery in Kaduna and Ogun States and
consolidate a platform of evidence to guide future programme delivery and research studies.
We situate our findings within the broader NTD literature, specifically, in identifying how our
findings align to existing reviews focused on factors that shape individual acceptance of MAM.
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Author summary
Nigeria has the highest number of people affected by neglected tropical diseases in sub-
Saharan Africa. Many of these diseases (onchocerciasis, lymphatic filariasis, schistosomia-
sis and soil transmitted helminths) can be prevented and treated using mass administra-
tion of medicines (MAM), which involves giving everyone in communities medicines
based on their height. MAM has been going on for a long time in Nigeria and has achieved
many successes, however, the programmatic, social, political and economic context in
Nigeria is rapidly changing and there is limited evidence about the ability of current
MAM approaches to ensure everyone who needs these medicines is able to access them
during this time of change. We asked MAM programme implementers at different levels
of the health system in Nigeria to tell us what they thought the key strengths and weak-
nesses of the current programme were and what they would do to make it better to ensure
that everyone who needs the medicines would still be able to access them. They told us
that the commitment of health workers and community leaders to telling communities
about the medicines and encouraging them to accept them as well as the knowledge of the
disability these diseases can cause had supported programme success. However, they also
told us that in some areas, such as those with security concerns or where communities feel
fatigued by the programme, the way communities respond is changing. To address the
change in community responses our study participants felt that we need to support pro-
gramme implementers with the time, tools and resources to build stronger more trusting
relationships with communities to ensure everyone can access medicines.
Introduction
Neglected tropical diseases (NTDs) affect the most impoverished and marginalised popula-
tions in the world [1]. Over the last three decades NTDs have received considerable attention
and funding, with most recent efforts being targeted toward the attainment of commitments
detailed in the London Declaration that pursue the control and elimination of selected NTDs
by 2020 [1]. Strategies to reach the targets build on existing approaches, one of which is the use
of community directed intervention (CDI) methods to deliver the mass administration of
medicines (MAM), i.e. distribution of freely donated medicines at scale, to tackle five of the
world’s most prevalent NTDs: lymphatic filariasis (LF), onchocerciasis, schistosomiasis, soil
transmitted helminths (STH) and trachoma [2]. MAM has become the primary public health
intervention aimed at reaching control and elimination of these diseases [3] and such
approaches have been largely successful in reaching those in need. However, treatment has
been inconsistent and there are questions about the sustainability of these intervention suc-
cesses during periods of programmatic, social, and political change [4,5]. As we have reached
2020, it is critical that we evaluate the successes and challenges of implementing MAM to
ensure the equitable attainment of the ‘end game’ in diverse and rapidly changing settings [6].
CDI approaches originated in 1995 from the African Programme for Onchocerciasis Con-
trol (APOC), which emphasised community engagement as a central component of MAM and
established a clear process for community directed treatment with ivermectin [7]. The process
relied on sensitisation and mobilisation of community members to select a volunteer commu-
nity directed distributor (CDD), who the community would support in kind (and/ or cash) to
deliver medicines house to house, to every eligible community member [7]. Since inception,
this approach has been used in many settings globally and is the key delivery mechanism for
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MAM in trachoma, LF, onchocerciasis and community-based STH and schistosomiasis pro-
grammes [3].
Nigeria has the largest burden of preventive chemotherapy neglected tropical diseases (PC
-NTDs) in sub-Saharan Africa [1]. A large proportion of this burden is due to the five most
prevalent NTDs targeted by MAM. Therefore, CDI approaches have become a standard model
of delivery for preventative chemotherapy in Nigeria [8]. Nigeria was one of the pilot sites for
APOC and has a long history of CDI for NTDs. In recent years, scale-up of MAM has been
supported nationally across all target States [8]. This provides a good opportunity to study
how NTD programmes can adapt to meet the needs of culturally and religiously diverse popu-
lations, some of whom live in fragile or security compromised areas, 50.2% live in urban areas
and a further 6.8% are nomads [8–10]. The country operates a federal system of government
that the NTD program also adopts. The Federal Ministry of Health (FMoH) is responsible for
supervision and training of the state and this is cascaded to the Local Government, the front-
line health facility (FLHF) staff and then the CDD [11]. The country has 36 states and 774
local government areas (LGAs) within those states which are diverse epidemiologically and
programmatically.
This paper draws on the findings of implementation research in Nigeria, conducted with
funding from the COUNTDOWN research consortium supported by the UK Department for
International Development (DFID). The aim of this study was to explore current strengths
and weaknesses of CDI approaches in MAM delivery and provide recommendations of good
practices and implications for future research. Specifically, we consider the importance of
using CDI principles for effective co-ordination of MAM activities and consider the challenges
of implementing these strategies in large, diverse programmes over an extended period.
Materials and methods
Ethics statement
The study was approved by the Ethics Boards of the Liverpool School of Tropical Medicine
(Reference: 15.043RSa) and the Nigerian Federal Ministry of Health (Reference: NHREC/01/
01/2007-13/01/2017). All participants were informed about the purpose of the study and pro-
vided written informed consent.
Study setting
In this study, we used qualitative methods to capture the tacit knowledge of programme imple-
menters at varying levels of the health system to present the current and emerging context of
MAM delivery in Kaduna and Ogun states.
Data for the study was collected at national level and from two states, Kaduna (north-west)
and Ogun (south-west). Their selection helped to achieve maximum variation in context and
to understand how a difference in implementation and funding options influence the NTD
programme in both states. The states represent maximum diversity due to differing cultural
composition, with Kaduna consisting of a mainly Hausa population, and Ogun having a
mainly Yoruba population. Typically, Ogun is also viewed as a more ‘secure’ state than
Kaduna, with Kaduna experiencing periods of religious fraction and ethnic violence. Both
Kaduna and Ogun states are endemic for four of the five PC NTDs, onchocerciasis, lymphatic
filariasis, soil transmitted helminths and schistosomiasis. Community directed treatment for
PC NTDs has been ongoing for 20 years in Kaduna and 18 years in Ogun [11]. The NTD pro-
gramme in Kaduna receives significant funding from the UK Department for International
Development (DFID) and technical support from the non-governmental organisation (NGO)
Sightsavers, whilst Ogun State receives limited funding from the United Nations Children’s
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Fund (UNICEF) and the World Health Organisation (WHO) on an ad-hoc basis. Ogun state
received no technical support from NGOs as at the time of this study.
Sampling
Within each State, three LGAs were purposively selected to ensure maximum variation in dis-
ease prevalence, programme impact (measured by geographic and therapeutic treatment cov-
erage), culture and geography. In Kaduna, one (State) with a border LGA, one northern LGA,
and one southern LGA were selected. In Ogun, one central LGA, one eastern LGA, and one
border (Country) LGA were selected. Variation in urban/rural LGAs was also aimed for across
the sample. Characteristics of each LGA are shown in Table 1.
Study design and participants
Key informant interviews were conducted with programme implementers at different levels of
the health system (national/Federal, State, and LGA). Participatory stakeholder meetings were
also conducted with LGA health implementers, health facility staff, CDDs and teachers. A
qualitative approach was used to allow stakeholders at all levels of the NTD programme to
share their experiences. The inclusion of stakeholders at all health systems levels supports to
address the top down approach to health and intervention design in Nigeria. Key informant
interviews took a semi-structured approach and covered a range of topics including successes
and challenges of programme implementation and recommendations for strengthening com-
munity engagement. Stakeholder meetings with key implementers drew on participatory
methods where participants considered and discussed implementation strengths, weaknesses,
challenges, and recommendations for improvement.
Purposive sampling was used to select participants for both methods, ensuring good pro-
grammatic knowledge and representation from the different levels of health governance in
Nigeria. Key informants included NTD programme managers, programme co-ordinators,
desk-deworming officers and representatives from civil society. Forty-two key informant
interviews were completed as shown in Table 2. CDDs, teachers and health facility staff were
also purposively selected from a sample frame of these cadres in each LGA. Other characteris-
tics, such as length of service to the programme, sex and age were also considered. Twelve
Table 1. Selected LGAs.
States LGA Selected Reported therapeutic coverage of community-based MAM (2016) (%)
Onchocerciasis1 Lymphatic1 Filariasis/Soil
Transmitted Helminths
Schistosomiasis (School
Based)
Urban/Rural (based on programmatic classification of
these areas using population density)
Kaduna
[12]
Ikara 80 80 N/A Rural
Igabi 76 76 99 Urban
Kachia 78 78 94 Urban
Ogun[12] Yewa North 78 78 68 Rural
Ijebu East 54 54 57 Rural
Abeokuta
North
692 402 31 Mixed
1 Co delivered through the same platform.
2 These figures are slightly different due to variance in the target population of the intervention in this LGA. Those in urban sections of this LGA do not receive
onchocerciasis treatment.
https://doi.org/10.1371/journal.pntd.0008857.t001
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participatory workshops were completed, one per cadre in each selected LGA. For a break-
down of participatory workshop participants please see Table 3.
Data collection and analysis
Data collection took place between January and March 2017 by three data collection teams
who had been trained for one-week. Study instruments were piloted and modified. Iterative
modifications to the data collection tools were also made during the data collection period to
ensure the study addresses all research questions. Each interview took approximately one
hour, and workshops were approximately 2 hours.
All State data was collected and audio recorded in the local languages, Hausa (Kaduna) and
Yoruba (Ogun); and Federal interviews were conducted in English. Data collection took place
in a location of participants choosing that was deemed safe for both researcher and participant.
Interviews were transcribed verbatim and translated to English, where necessary, a sample
were back translated, and recordings were checked for accuracy. Records and notes from
observations at the workshops were typed to supplement the analysis. Data was analysed the-
matically using Atlas.ti (version 6) software. Each of the research team leads led the analysis
process with support from the UK research team and in collaboration with national NTD pro-
gramme partners. The framework approach was used to analyse the data [13].
Results
Our results can be broadly split into two thematic areas; acceptability and adaptability. Key
components of CDI approaches such as the critical role of community leaders in engaging
communities for MAM; and the fundamental role of the health workforce in sensitisation and
mobilisation, were described by participants as vital components of programme delivery that
are continuing to shape medicine acceptance amongst community members. Beliefs and per-
ceptions about medicines and their side effects were also found to be critical in shaping accep-
tance. The ability of CDI approaches to adapt to variations in socio-political circumstance due
Table 2. Key informant interview participants.
Kaduna Ogun
International NGDO Partner 5
Federal Ministry of Health 5
State Ministry of Health 4 4
Local Government Authority (LGA) 9 15
Total 42
https://doi.org/10.1371/journal.pntd.0008857.t002
Table 3. Participatory workshop study participants.
State LGAs Participatory Workshop Participants by Gender
FLHF staff workshop CDD workshop Teacher workshop
Male Female Male Female Male Female
Kaduna Kachia 3 12 6 6 12 3
Igabi 13 2 14 1 14 0
Ikara 9 6 14 1 15 0
Ogun Abeokuta North 0 15 10 4 6 9
Ijebu East 0 15 6 9 4 11
Yewa North 7 8 10 3 4 11
Total 32 58 60 24 55 34
https://doi.org/10.1371/journal.pntd.0008857.t003
PLOS NEGLECTED TROPICAL DISEASES Mass drug administration in emerging and diverse contexts
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008857 November 25, 2020 5 / 18
to issues such as insecurity, urbanisation, migration, and changing development priorities also
emerged as key issues impacting programme success. Finally, adaptability at the micro-level in
relation to gender and livelihoods also influenced the ability of certain population groups to
access medicines. Each of these areas are discussed within the subsequent results section.
Acceptability
Community leaders remain critical in community engagement for MAM. Some CDDs
and teachers, and most FLHF staff, described that community leaders and associated struc-
tures such as religious groups, village health committees and market associations were critical
in shaping how communities responded to MAM. Participants explained that the person who
delivers health messaging shapes the authenticity of information and medicines. Timing and
quality of information that was provided was pivotal to programme success or failure. For
example, if information is only provided to community leaders the day of or immediately
prior to the programme, they are unable to adequately sensitise their community members. In
addition, where information was rushed, incomplete or lacking in content, a few CDDs and
teachers described that community leaders struggled to share information that would instigate
behaviour change and promote medicine acceptance.
‘The community accepts the medicines although there are usually not enough posters and not
enough time during implementation for sensitisation in the markets places, churches and
mosques’
(Participatory meeting with FLHF, Ikara LGA, Kaduna State)
‘Unfortunately, the level of information about this program. . .has reduced and that is why we
have serious challenges with people accepting the medicines as compared to the previous year’
(Participatory meeting with CDDs, Ijebu East LGA, Ogun State)
Just as community leaders can be an asset to the programme, without adequate engagement
they can also be a hindrance. For example, if as gatekeepers they are not well informed or do
not have a positive perception of the programme, some FLHF Staff described that they would
share messages that may result in community members not accepting medicines.
‘Where community leaders are not aware of the medicine distribution they won’t accept it
and would also tell their community members not to take the medicines’
(Participatory meeting with FLHF, Abeokuta LGA, Ogun State)
In areas less familiar with CDI approaches, or where new community leaders had emerged,
FLHF staff described increasing challenges in the engagement of community leaders due to an
expectation of the provision of incentives in exchange for their co-operation. They described
this as being due to the initiation of other community health initiatives, such as the polio pro-
gramme who were providing such incentives.
The fundamental role of the health workforce in community mobilisation and sensitisa-
tion: what happens when they get tired? State NTD implementers and frontline health facility
staff mainly reported the need for their continuous engagement with the community through
sensitisation meetings, particularly prior to MAM. All FLHF staff reported that this helped cross-
community information sharing, where participants from different communities were often pres-
ent in each other’s meetings, resulting in them taking messages back to their own community in
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advance of their community meeting. CDDs were described to play a critical role in the continu-
ous engagement process, particularly when they had been selected by the community.
‘The community accepts the drugs during the implementation and this is because they have
been sensitized. During the exercise prior to our arriving at the next community the people in
the previous community have informed each other and will rush to where we are so that they
can get the drug’
(Participatory Meeting FLHF Staff, Ikara, Kaduna).
FLHF staff and CDDs described CDDs as the connection point between formal health staff
and communities, thus taking on the dual role of a community gatekeeper and forming a cru-
cial part of programme delivery. In areas where CDDs had been selected in the ‘traditional’
CDI manner through the use of participatory community meetings, most CDDs and FLHF
staff described that community members were accepting of the medicines, mainly because
they trusted the CDD. However, some CDDs did describe being challenged or facing criticism
by communities, with some community members describing them as ‘jobless people who go
about distributing medicines’ (Participatory meeting, CDDs, Yewa North,Ogun State).
Despite ongoing dedication of health workers and CDDs, in areas where the NTD pro-
gramme has been implemented for many years (sometimes over 27), community and staff pro-
gramme fatigue were described by key informants as having led to a complacency regarding
community sensitization. In addition, FLHF staff, teachers and CDDs also reported sometimes
leaving out ‘geographically hard to reach areas’ due to inadequate support and programme
resources, specifically transportation that resulted in them frequently having to use their own
resources. Consequently, acceptance of the programme in these areas was compromised, par-
ticularly where praziquantel has been integrated with other programmes without an appropri-
ate level of community mobilisation around side effects and their management.
‘I (stammers) have put in a letter, I want to leave this NTD program because I’m tired, it’s my
money I’m using to go round the communities,money which I’m supposed to use and feed my
family I go round the Local Government, you know my Local Government is one of the largest
local Governments in Kaduna so I’m tired of the lack of response.When you go to them (gov-
ernment) they will say sacrifice’
(KII, LGA Level, Kachia, Kaduna).
Syncretic belief systems and mis-information on medicines
Across both states, religious and traditional beliefs were thought to present a challenge to pro-
gramme acceptance. For example, health workers in Kaduna and teachers in Ogun described
that programme acceptance was particularly low where community members believed in
prayer or the use of herbs to prevent disease (particularly when they were attributed to non-
medical causes). In Kaduna, health workers described this as particularly pronounced where
traditional healers were not engaged in sensitisation or programme delivery.
‘In my opinion, not all of them (community members) accepted us, they don’t believe in ortho-
dox medicine, they will rather take herbs and concoctions than take the medicines we offer
them even though it’s for free’
(Participatory Meeting with CDDs, Ijebu East, Ogun).
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Beliefs about the purpose and origin of medicines also shaped how communities engaged
or interacted with MAM. For example, in Kaduna State, particularly in the northern LGAs,
most teachers, State and LGA key informants, reported that medicines were often thought to
be linked to family planning and would either prevent pregnancy or make men impotent.
‘Rejection of medicines was due to side effects such as vomiting, dizziness, big size of the medi-
cines and the fact that some people believe that it is for family planning’
(Participatory Meeting with Teachers, Igabi, Kaduna).
The fact that medicines were free had differing impacts on community engagement with
the programme. For example, in Kaduna State, some frontline health facility staff and most
CDDs described that the medicines being free often meant that community members felt
the medicines were being distributed with ulterior motives, they were not good, or not
genuine and as a result they refused to swallow the medicines, thereby requiring additional
sensitisation.
‘Some would say that any free drug is not a good drug as far as they are concerned’
(Participatory Meeting with FLHF Staff, Ikara, Kaduna).
In Ogun State however, the fact that medicines were free often meant increased levels of
acceptance:
‘Another success to the community is that the medicines are free of charge, and they are
happy that government remembers them’
(Participatory Meeting with FLHF staff, Yewa North,Ogun).
Side effects and medicine benefits
Side-effects (mainly vomiting and dizziness) and in some rare cases severe adverse events
(SAEs) were reported by all participants as a factor that decreased acceptability of MAM and
led to high levels of refusals. National key informants described that despite best efforts to sen-
sitise communities using ‘radio jingles’, non-participation in the programme due to side effects
was still a major issue.
‘At times, those that have drug reactions once they take it they won’t come back complaining
that ‘it itches me’, ‘my body is swelling’, ‘it is causing eruptions’ they will not come back they
won’t use the drug again it will be abandoned’
(Participatory Meeting with frontline health facility staff Abeokuta LGA Ogun).
In Kaduna, most teachers described that pupils tended to experience side effects because of
not having eaten prior to taking the medicines. To overcome rejection of medicines due to
side effects, some LGA and State key informants described that they had initiated additional
training for head teachers and other teachers, particularly around praziquantel, so that they
were better equipped for sensitisation and the management of side effects.
Some state key informants also described encouraging better engagement with the frontline
health facility during school-based deworming campaigns, either through the referral of pupils
to the facility when experiencing side effects, or by asking the health worker to be present
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during the distribution of the drug to monitor the pupils for side effects. These additional steps
had enabled increased acceptability of the medicines by some parents and communities.
Additional reported benefits in physical health such as children passing out worms, often
allowed community members to link MAM to educational messages therefore promoting pro-
gramme acceptance. These improvements in physical health (such as less complaints of stom-
ach ache and passing blood in urine) were viewed as contributing toward increased school
enrolment, attendance and performance.
‘It also helps to prevent worms. They also result in good performance of the pupils and
increased turn out of students. This is because parents were encouraged to send their children
to school just for the sake of taking these medicines’
(Participatory Meetings with Teachers, Ikara, Kaduna).
Adaptability
Within the following sub-themes, we present illustrative examples of how key changes in
socio-political circumstance (e.g. urbanisation) and social-power relations (e.g. gender) require
adaptation to existing programme delivery approaches to ensure equity in programme access.
Urbanisation and insecurity. Key informants described that sensitisation can be chal-
lenging in urban and peri-urban areas where community leaders have less influence and con-
trol due to increased heterogeneity and less collective opinion. Some key informants reported
trying to adapt to overcome this through advice from leaders; suggestions included greater
sensitisation at communal gathering points and more targeted sensitisation in some areas.
This challenge was further exacerbated in areas of political insecurity, particularly when FLHF
staff could not access these areas to engage with community leaders. CDDs did not necessarily
see this as their role and so medicines are distributed without engaging leaders potentially
reducing acceptance and compromising implementation. In security compromised areas, key
informants also described engaging these leaders for monitoring activities.
‘You see the communities we have in this Local Government within the past 2 years, we had
to revisit. . ..because there is insecurity, kidnapping, with Fulani attacking the communities
especially in the western part of the Local Government making the community leaders in
those communities to help monitor activities.’
(KII LGA Staff, Kachia, Kaduna).
Shifting community priorities: Knowledge of visible morbidities and
medicine delivery
Where ivermectin had been distributed for a long time, there was often a high level of demand
for the programme. Key informants at the State and LGA level and some CDDs linked this
demand to the visible morbidity caused by these diseases, either in existence in the community
or as depicted in IEC materials used during advocacy visits. In Ogun state, informants and
CDDs particularly linked this to onchocerciasis related blindness and a loss of livelihood activ-
ities or fear of starvation due to no longer being able to farm.
‘In some cases, in which the affected person with the disease is a farmer, he would not be able
to do farming activities anymore or even if he can still manage to farm he will not be able to
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do much. Or in the case of someone with river blindness, he will not be able to do any work.
He will just be at home, starving which is why they (community members) are asking for the
medicine’
(Participatory Meeting with CDDs, Ijebu East, Ogun).
Despite these perceived benefits, in Kaduna State teachers and CDDs reported that there
are increasing challenges with people refusing to take medicines due to a lack of perceived
need (i.e. they are not sick) or a lack of visible morbidity. They described this as being exacer-
bated in areas where NTD morbidity prevalence or burden had been reduced (a key success of
the NTD programme), with some key informants at the federal level describing that some
communities feel that the programme has worked and is therefore no longer necessary.
‘Some elderly people refuse to take the medicines because they feel they don’t need them as
they are healthy without taking the drug’
(Participatory Meeting with CDDs, Kachia, Kaduna).
‘Sometimes we come across people that reject the medicines because they don’t understand the
importance of the medicines as they believe that there is nothing wrong with them physically’
(Participatory meeting FLHF staff, Ikara LGA, Kaduna State).
Some CDDs and FLHF staff in Ogun and Kaduna perceived that communities were more
reluctant to accept MAM and engage with the NTD programme when their other development
needs were not being addressed. They described higher levels of medicine refusal where com-
munities felt that they had competing community priorities such as a need for better infra-
structure, provision of food, safe drinking water and fertilisers. Poverty was also frequently
cited as the main concern of the target communities.
‘if we get to the community some of the elders will say they are hungry and we are giving them
medicines do we want hunger to kill them? Do we want them to use the drug on an empty
stomach?’
(Participatory meeting with CDDs, Abeokuta North LGA, Ogun State).
Migrant groups. In Kaduna State, LGA officers reported that within migrant populations,
such as Fulani, failure to adapt sensitisation processes to align to their traditional cultural prac-
tices can compromise the success of the programme. For example, not eating food provided by
the Fulani prior to offering them the medicines will result in instant refusal. The use of measur-
ing sticks for distribution will also lead to refusals as sticks are used to measure corpses. Key
informants described enhancing training for CDDs to address these issues but also explained
that more needs to be done to ensure their continued engagement with the programme.
‘In some communities they don’t allow us to use sticks in measuring their height because that
is how they usually take measurement of the dead for burial arrangements and hence the
belief that if they are measured they will die soon’
(Participatory Meeting with CDDs, Kachia, Kaduna)
Cultural and language variation. In Ogun State, some FLHF staff also described distribu-
tion challenges based on cultural variations. In some communities where there are groups
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from multiple tribal backgrounds, community members from the ‘non-host’ tribe would
refuse medicines as they thought that they were designed to harm them. This was particularly
common in boarder areas and FLHF staff described having to enhance sensitisation activities
to these populations and in other areas where language was not shared. In instances where
health workers and community members had no common dialect, this often resulted in medi-
cine refusal.
‘We talk about challenges which are language barriers. In some of our communities we have
Hausa, Yoruba, Cotonou are there. I hear a kind of Ijebu, when we want to talk to them that
they should use the drug.We don’t understand each other. It is a barrier and it’s difficult to
convince them. So, we will look for intermediary that will help us interpret. Religion barrier is
there.We all know them, this people that believe in healing without medicine. They will collect
it but keep it down and some will reject it’
(Participatory Meeting with FLHF, Ijebu East,Ogun).
‘There is a complete ward that is sometimes left out because it is hard-to-reach X ward
because of distance and terrain. Other places include X and X having distance and insecurity
issues’
(KII, LGA Level, Igabi, Kaduna).
Gender roles and livelihoods. Most CDDs reported difficulty in accessing certain house-
holds especially where for religious reasons male CDDs had limited or no access to female
members of the household without the permission of the head of the household. This was
exacerbated where men worked outside of the community. In communities that were agrarian,
CDDs reported difficulty in reaching people who were farmers and hunters during the rainy
season. Those who were long distance drivers and had to leave their homes early in the morn-
ing also posed a challenge as shortened distribution times didn’t allow for more time to keep
going back to these houses.
‘more males and females should participate in the program because the male CDDs are not
allowed to enter some houses in such cases it’s the females that are allowed in to administer
medicines in that particular family, so we suggest that more females should be involved’
(Participatory Meeting with FLHF, Ikara, Kaduna)
‘Why people are missed is because some will go to the farm and will not come back on time.
When you get to their houses you might not find them at home.
(Participatory Meeting with FLHF, Abeokuta North, Ogun)
Discussion
Overall, our results indicate that generally, CDI approaches have provided an acceptable plat-
form for reaching at-risk communities with preventive health services (particularly MAM).
However, there are still some adaptations that could be made to programme delivery to
increase and sustain programme equity.
In their 2013 review, Krentel et al, identify ‘five key ingredients’ that are essential in shaping
individual acceptance of MAM, with specific relation to LF. These ingredients include: 1)
Acknowledging the role of trust in MDA; 2) tailoring a distribution system that is appropriate
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to the local environment; 3) management of adverse events; 4) promotion of other ‘non-health’
benefits of compliance; and 5) addressing the issue of systematic non-compliance [14]. CDI
approaches have been frequently described as the best way to achieve these ‘key ingredients’
and factors that have contributed to the success of the approach have been largely documented
in the literature and reflected in this study are; homogeneity of rural communities, rigorous
mobilisation and sensitisation techniques supported by the presence of visible morbidity in
communities, motivated and engaged community leaders and health workers [14] (see Fig 1).
However, factors that disrupt the CDI model and ability of MAM to achieve these ‘five key
ingredients’ are less documented. Fig 1 below illustrates key disrupting factors to the attain-
ment of these ‘five key ingredients’ emerging from our analysis of existing CDI approaches for
MAM in Kaduna and Ogun state. Our discussion is structured around each of these ‘key ingre-
dients’ where we explore how changes in context can present challenges to CDI approaches in
their current form.
Challenges in establishing trust in alternative contexts and maximising the
use of social capital
Community directed approaches as the key delivery platform for MAM have relied heavily on
the homogenous nature of rural communities to sustain engagement. Sensitisation and aware-
ness activities through appropriately chosen community leaders and structures which build on
social capital and trust have been of great benefit to both community and school-based MAM
interventions [14,15]. Our results reinforce this highlighting that the structure of typical rural
communities in Nigeria, underpinned by strong kinship ties [16,17], has been of historical
benefit to the implementation of the NTD programme in establishing trust and consequent
acceptance of medicine delivery. However, urbanisation, migration and an increase in pres-
ence of security compromised areas in Nigeria has continued to have an influence on the
socio-cultural landscape, with community structures and belief systems adapting, becoming
more diverse and in many areas family and kinship ties weakening [18]. This has presented a
challenge for the programme in establishing and maintaining trust in less homogenous set-
tings such as those that are more urban or experiencing periods of instability [15]. Under-
standing who and what structures to engage with in alternate contexts where community
leaders or organisations have less control over collective opinion is therefore critical for the
NTD programme in establishing trust and in ensuring medicine acceptance. This requires
Fig 1. Engaging and disrupting factors for a successful community engagement program.
https://doi.org/10.1371/journal.pntd.0008857.g001
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new partnerships that reflect different contexts and is essential to ensure no one is left behind
in programme delivery.
Molyneux (2018) identified socio-political upheavals such as conflict, disease outbreak and
or environmental impacts as a challenge to achieving NTD elimination targets, stating a need
for innovative approaches to program delivery [10]. Our results show that face to face interac-
tions with health workers and CDDs are essential in establishing trust and rapport with com-
munities and their leaders [14]. Where access to communities for health workers was limited
based on security issues, challenges in establishing trust were exacerbated. Our results high-
light that reliance on tacit knowledge and engagement of residents (particularly community
leaders) and CDDs from security compromised areas is therefore critical in the use and devel-
opment of tailored approaches that ensure these areas are reached. Consequently, as suggested
by Gonzales et al (2019), our results support the idea that, when leveraged effectively social
capital (in the form of community leaders and others) has the potential to not only increase
programme acceptance but also support the design, delivery and monitoring of MAM and
other health interventions [15].
Tailoring distribution strategies to the local environment: Programmatic
challenges and a need to adapt to the cultural context
As emphasised above, community leaders are an invaluable resource for MAM programme
delivery and programmes working with leaders have a greater chance of success [14]. As found
in other contexts [14], challenges with the quality and timing of information shared to com-
munity leaders limits their sustained engagement and affects their ability to share information
effectively with communities, ultimately compromising programme acceptance. Reasons
identified for inadequate engagement with community leaders were three-fold and normally
attributable to programme delivery challenges including: 1) delays in the drug supply chain,
meaning little time between training distribution and reporting, rendering CDDs unable to
adapt and cascade information messaging; 2) health worker fatigue and insufficient resources
to deliver appropriate sensitisation, resulting in substantial out-of-pocket expenditure by
frontline health personnel; and 3) an influx of other health programmes that provide incen-
tives for community leader engagement (e.g. polio) leading to dis-engagement from many
leaders when the MAM programme is unable to match such incentives. Programmatic factors
that compromise community directed approaches are not uncommon but require innovation
and adaptation [19]. Solutions to some of these programmatic challenges in other sub-Saharan
African contexts have included: standardisation of incentive structures across all disease pro-
grammes; and provision of monthly stipends and logistical supplies to community health
work cadres [20]. However, most of these solutions are critically dependent on the ability of
governments to adapt funding and implementation structures to financially and logistically
contribute toward supporting such efforts. Donors and programme implementing partners
should also be more flexible and responsive by instigating less restrictive reporting and fund-
ing structures. This will likely contribute toward enabling programmes to respond to their
own challenges and implement as they desire, ultimately moving away from chronic verticali-
zation [21] in the delivery of MAM to programmes that allow more flexible planning and
implementation at the local level.
MAM delivery currently relies on the roll out of a “one size fits all” approach to medicine
distribution. Whilst this has achieved many successes, as Parker and Allen suggest; ‘roll out of
a single policy in a uniform way is unlikely to be effective, inevitably it will be influenced by
the political, economic, historic and social context in which it occurs’[22]. This is exacerbated
as standardised approaches also move away from the true roots of the CDI model that rely on
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communities’ ownership [7]. Adapting distribution strategies to be responsive to the local
socio-cultural and programme delivery context is therefore essential in minimising an overre-
liance on top-down vertical approaches [21] and is critical to achieving equity in programme
delivery, even where overarching programme goals may already be achieved. There are key
sub-populations such as Fulani migrants where standardised elements of MAM delivery
including measurement using a stick are culturally unacceptable and challenge programme
acceptability. In areas where there are mixed tribal groupings, we also found that who is
selected as the CDD is of critical importance as notions of belonging and language matters
[23]. Small programme adaptations, such as taking a different approach to measurement,
selecting multiple CDDs from different social backgrounds and genders from within one com-
munity, or ensuring the modification of materials to meet different communication needs
would likely enhance programme equity [23].
The same was also true regarding gender norms, traditional and religious beliefs and their
interactions with programme acceptability. Syncretic belief systems that see the convergence
of ‘medical’ and ‘traditional’ understandings of medicines and disease often shape the accep-
tance of ‘westernised’ medicine or ‘formal’ health interventions in different ways in different
settings [24]. Some communities were described as refusing to accept medicines due to the
belief that more ‘traditional’ medicines were required to treat targeted diseases. Additionally,
in Ogun, medicines being donated for free pleased communities and made them feel of value
to the government, whilst in Kaduna, a convergence of religious and traditional belief systems
led to communities believing that medicines which are donated for free restrict fertility and
should not be trusted or accepted. Gendered norms also restricted access to some individuals
in communities, particularly in Kaduna where male CDDs could not enter certain households
without permission of the household head, creating the potential for some women to remain
‘invisible’ to the NTD programme when not treated or accounted for within programme rec-
ords [23]. There is a clear need for NTD programmes to develop sensitisation and awareness
activities that can respond to gendered norms and syncretic belief systems within target com-
munities to allow individuals to make appropriately informed choices about their willingness
to accept MAM [22]. Failure to do so can compromise the trust that communities have in
MAM and other health interventions. Cumulatively, all these factors emphasise that adaptabil-
ity to context is of critical importance in implementing MAM in this setting [3].
Management of adverse events and the introduction of new medicines
Across many contexts, experience of, and rumours about side effects and in some cases
extreme adverse events are some of the most documented challenges in ensuring the accept-
ability of MAM [14]. Results in this study supported these findings indicating that side effects,
mainly vomiting and dizziness, were described by informants as decreasing the acceptability of
MAM leading to high levels of refusals. Side effects tended to be identified in relation to the
distribution of praziquantel, particularly in the initial years of MAM when disease burden is
highest [14,25]. Failure to adequately manage the experience of side effects and adverse events
or conduct sensitisation regarding the risk and likelihood of certain types of side effects is
known to and as supported here have negative impact on programme outcomes [26]. Within
the context of integrated programme delivery, it is critical that these issues are addressed to
ensure that experiences and rumours regarding side effects in relation to one medicine, in this
case praziquantel, do not damage the long-standing trust or acceptance communities have
regarding the acceptance of other medicines (e.g. ivermectin) delivered through the same or
similar platforms. Best practices identified to ensure the effective management of side effects
are: intensive advocacy with community leaders; immediate action in response to side-effects
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using pharmacovigilance guidelines; additional and targeted training with community volun-
teers and health workers; and in the case of school-based deworming, strengthening cross-sec-
toral collaboration so that health workers are present during distribution. In prioritising the
integration of other diseases within strong existing community platforms, it is critical to
remember the impact and consequence this can have on community understandings, the com-
plexities it adds to health messaging, and the additional support needs of community volun-
teers and health workers to be able to manage integration efforts at the frontline [27].
Morbidity and changing priorities: A need to think beyond direct health
benefits
Sensitization efforts linked to MAM frequently emphasize the health benefits of a ‘treatment’
or ‘cure’ for targeted diseases. However, the steady decline of visible morbidity associated
with NTDs (a key programme success) combined with traditional beliefs about causes and
treatment has led to a low perceived need for MAM in some communities. Ultimately, as
Krentel et al (2013) describe ‘it is hard to convince people who feel well to take medicines’.
‘Wellness’ in this case is intrinsically linked to an individuals’ interpretation of ‘ill-health’
and not directly linked to biomedical understandings of disease [24]. Although not true in all
areas, with some still experiencing current or memories of physical morbidities linked to
onchocerciasis, there is a need for the NTD programme to be able to adapt sensitization mes-
saging to focus on more than just the ‘treatment’ or ‘cure’ of target diseases. Other non-
health benefits identified by respondents in our study that could be capitalized in more
diverse sensitization activities are increased school attendance, reduction in lice and an
increase in libido, and the use of patient advocates. Without significant adaptation to sensiti-
zation messaging, our results indicate that despite short-term acceptance in areas where high
levels of visible morbidity are experienced, sustained engagement with MAM interventions
is likely to be compromised.
Finally, our results also show that changing and wider development priorities amongst
community members also shaped program acceptance. Preferences for food and infrastructure
(such as roads and bridges) were prioritised by community members who disengaged with the
programme as they could not understand why this programme would continue when they had
greater needs in other areas. The links between NTDs and the broader environment are well
established, and wider social determinants including agricultural infrastructure, irrigation
systems and improved sanitation are critical in striving toward elimination of these diseases
[28,29]. There is, therefore, a unique and essential opportunity for NTD programmes to be
able to partner across sectors to address structural determinants of NTD risk whilst respond-
ing to community identified development priorities that may also contribute to enhanced
medicine uptake.
Addressing the issue of persistent refusals: A missing link for programme
implementers?
Persistent refusal was not raised as a key issue by programme implementers. However, some
of the key issues raised above including the impact of side effects, challenges in creating trust
and rapport with communities, and a lack of perceived need of medicines, are all likely to con-
tribute toward a persistent dis-engagement with the NTD programme for some individuals.
Further work and discussions are therefore necessary with programme implementers at all lev-
els in Nigeria to understand how to identify and engage with persistent refusers to avoid ‘con-
tinued sources of infection’[14] within target communities.
PLOS NEGLECTED TROPICAL DISEASES Mass drug administration in emerging and diverse contexts
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008857 November 25, 2020 15 / 18
Strengths and weaknesses
A key limitation of our study was the absence of the ‘voices’ of community members. However,
this study was designed to serve as a context analysis for latter pieces of work and we felt that
the engagement of multiple groups of CDDs who serve as a link point between communities
and the health system would support in mitigating this challenge. A key strength of our research
was being able to engage with implementers from varying levels of the health system using par-
ticipatory and in-depth methods that allowed these actors to express their views and concerns
in their own way and based on their own priorities. Many implementers reflected throughout
data collection on how this was rare for them despite having been engaged in multiple research
studies and working for the NTD programme for many years. Finally, the collation of data from
across two very diverse states in Nigeria contributes towards the generalisability of our findings,
however in future work, the inclusion of states from all geo-political zones based on contextual
variability would further enhance this studies generalisability.
Conclusion
Nigeria has Africa’s largest NTD burden and has achieved a lot of successes to date utilising
the CDI model in the MAM. Meeting the 2020 targets and achieving the ‘end game’ in chang-
ing contexts will require additional efforts and strategies. Understanding factors that currently
disrupt the CDI model, presented in this paper, will be critical. Addressing these factors means
supporting frontline providers with the time, tools, resources and supervisory structures to
enable them to build strategic and trusting relationships with fluid and changing communities
in different contexts thereby ensuring no one is left behind.
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